Variables | Total (n = 779) | Elderly patients (n = 135) | Younger patients (n = 644) | p-value |
Therapeutic modalities (%) |
|
|
|
|
Confinement à domicile | 596 (76.5) | 81 (60.0) | 515 (80.0) | <0.0001 |
Hospitalisation | 183 (23.5) | 54 (40.0) | 129 (20.0) | |
Type of treatment (%) |
|
|
|
|
Antiasthenic | 648 (83.2) | 77 (57.0) | 571 (88.7) | <0.0001 |
Antibiotic | 515 (66.1) | 106 (78.5) | 409 (63.5) | 0.0008 |
Analgesic-antipyretic | 237 (30.4) | 23 (17.0) | 214 (33.2) | <0.0001 |
Oxygen | 136 (17.5) | 90 (66.7) | 102 (15.8) | <0.0001 |
Glucocorticoid | 136 (17.5) | 85 (63.0) | 81 (12.6) | <0.0001 |
Anticoagulant | 136 (17.5) | 103 (76.3) | 33 (5.1) | <0.0001 |
Flu medication | 18 (2.3) | 3 (2.2) | 15 (2.3) | 0.940 |
Antitussive | 6 (0.8) | 3 (2.2) | 3 (0.5) | 0.068 |
Bronchodilatator | 6 (0.8) | 3 (3.7) | 2 (0.2) | 0.053 |
Anxiolytic | 3 (0.4) | 2 (1.5) | 1 (0.2) | 0.079 |
Proton Pump Inhibitor (PPI) | 1 (0.1) | 1 (0.7) | 0 (0.0) | 0.173 |
Duration of confinement (day) |
|
|
|
|
Median (IQR) [Min - Max] | 13 (11 - 15) [0 - 65] | 13 (10 - 16) [0 - 57] | 13 (11 - 15) [0 - 65] | 0.551 |
Evolution (%) |
|
|
|
|
Favourable | 724 (92.9) | 103 (76.3) | 621 (96.4) | <0.0001 |
Death | 55 (7.1) | 32 (23.7) | 23 (3.6) |